HGNC Symbol | HAGRID | Common name | Function(s) | References | Interactions |
---|---|---|---|---|---|
A2M | 139 | alpha-2-macroglobulin | 5 | 21 | |
ABL1 | 78 | ABL proto-oncogene 1, non-receptor tyrosine kinase | 5 | 69 | |
ADCY5 | 255 | adenylate cyclase 5 | 1 | 1 | |
AGPAT2 | 187 | 1-acylglycerol-3-phosphate O-acyltransferase 2 | 3 | 0 | |
AGTR1 | 264 | angiotensin II receptor, type 1 | 5 | 2 | |
AIFM1 | 135 | apoptosis-inducing factor, mitochondrion-associated, 1 | 4 | 16 | |
AKT1 | 35 | v-akt murine thymoma viral oncogene homolog 1 | 45 | 91 | |
APEX1 | 195 | APEX nuclease (multifunctional DNA repair enzyme) 1 | 11 | 40 | |
APOC3 | 102 | apolipoprotein C-III | 7 | 0 | |
APOE | 138 | apolipoprotein E | 28 | 11 | |
APP | 137 | amyloid beta (A4) precursor protein | 35 | 125 | |
APTX | 95 | aprataxin | 6 | 6 | |
AR | 110 | androgen receptor | 8 | 91 | |
ARHGAP1 | 249 | Rho GTPase activating protein 1 | 1 | 9 | |
ARNTL | 251 | aryl hydrocarbon receptor nuclear translocator-like | 11 | 16 | |
ATF2 | 193 | activating transcription factor 2 | 10 | 59 | |
ATM | 9 | ATM serine/threonine kinase | 42 | 75 | |
ATP5O | 146 | ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit | 3 | 4 | |
ATR | 231 | ATR serine/threonine kinase | 7 | 49 | |
BAK1 | 278 | BCL2-antagonist/killer 1 | 3 | 11 | |
BAX | 119 | BCL2-associated X protein | 21 | 23 | |
BCL2 | 69 | B-cell CLL/lymphoma 2 | 30 | 47 | |
BDNF | 191 | brain-derived neurotrophic factor | 27 | 2 | |
BLM | 68 | Bloom syndrome, RecQ helicase-like | 15 | 45 | |
BMI1 | 188 | BMI1 proto-oncogene, polycomb ring finger | 13 | 41 | |
BRCA1 | 61 | breast cancer 1, early onset | 21 | 131 | |
BRCA2 | 79 | breast cancer 2, early onset | 8 | 26 | |
BSCL2 | 186 | Berardinelli-Seip congenital lipodystrophy 2 (seipin) | 3 | 0 | |
BUB1B | 197 | BUB1 mitotic checkpoint serine/threonine kinase B | 10 | 25 | |
BUB3 | 240 | BUB3 mitotic checkpoint protein | 4 | 16 | |
C1QA | 287 | complement component 1, q subcomponent, A chain | 1 | 2 | |
CACNA1A | 133 | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | 7 | 4 | |
CAT | 107 | catalase | 37 | 15 | |
CCNA2 | 177 | cyclin A2 | 3 | 39 | |
CDC42 | 250 | cell division cycle 42 | 2 | 24 | |
CDK1 | 201 | cyclin-dependent kinase 1 | 4 | 59 | |
CDK7 | 299 | cyclin-dependent kinase 7 | 0 | 33 | |
CDKN1A | 284 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 7 | 70 | |
CDKN2A | 226 | cyclin-dependent kinase inhibitor 2A | 35 | 50 | |
CDKN2B | 288 | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 2 | 2 | |
CEBPA | 88 | CCAAT/enhancer binding protein (C/EBP), alpha | 14 | 35 | |
CEBPB | 89 | CCAAT/enhancer binding protein (C/EBP), beta | 9 | 55 | |
CETP | 262 | cholesteryl ester transfer protein, plasma | 7 | 0 | |
CHEK2 | 247 | checkpoint kinase 2 | 8 | 35 | |
CISD2 | 265 | CDGSH iron sulfur domain 2 | 2 | 8 | |
CLOCK | 252 | clock circadian regulator | 17 | 12 | |
CLU | 220 | clusterin | 16 | 35 | |
CNR1 | 282 | cannabinoid receptor 1 (brain) | 4 | 0 | |
COQ7 | 132 | coenzyme Q7 homolog, ubiquinone (yeast) | 11 | 1 | |
CREB1 | 192 | cAMP responsive element binding protein 1 | 15 | 49 | |
CREBBP | 64 | CREB binding protein | 11 | 123 | |
CSNK1E | 244 | casein kinase 1, epsilon | 7 | 17 | |
CTF1 | 304 | cardiotrophin 1 | 0 | 4 | |
CTGF | 206 | connective tissue growth factor | 3 | 4 | |
CTNNB1 | 223 | catenin (cadherin-associated protein), beta 1, 88kDa | 16 | 102 | |
DBN1 | 228 | drebrin 1 | 4 | 20 | |
DDIT3 | 203 | DNA-damage-inducible transcript 3 | 4 | 19 | |
DGAT1 | 291 | diacylglycerol O-acyltransferase 1 | 0 | 1 | |
DLL3 | 225 | delta-like 3 (Drosophila) | 12 | 0 | |
E2F1 | 18 | E2F transcription factor 1 | 14 | 52 | |
EEF1A1 | 189 | eukaryotic translation elongation factor 1 alpha 1 | 5 | 43 | |
EEF1E1 | 266 | eukaryotic translation elongation factor 1 epsilon 1 | 3 | 0 | |
EEF2 | 103 | eukaryotic translation elongation factor 2 | 5 | 36 | |
EFEMP1 | 260 | EGF containing fibulin-like extracellular matrix protein 1 | 3 | 2 | |
EGF | 48 | epidermal growth factor | 15 | 13 | |
EGFR | 40 | epidermal growth factor receptor | 13 | 145 | |
EGR1 | 76 | early growth response 1 | 5 | 22 | |
EIF5A2 | 289 | eukaryotic translation initiation factor 5A2 | 0 | 0 | |
ELN | 230 | elastin | 9 | 2 | |
EMD | 121 | emerin | 4 | 27 | |
EP300 | 94 | E1A binding protein p300 | 11 | 161 | |
EPOR | 52 | Erythropoietin receptor | 5 | 16 | |
EPS8 | 267 | epidermal growth factor receptor pathway substrate 8 | 5 | 11 | |
ERBB2 | 41 | erb-b2 receptor tyrosine kinase 2 | 9 | 41 | |
ERCC1 | 149 | excision repair cross-complementation group 1 | 13 | 8 | |
ERCC2 | 11 | excision repair cross-complementation group 2 | 19 | 16 | |
ERCC3 | 104 | excision repair cross-complementation group 3 | 10 | 22 | |
ERCC4 | 261 | excision repair cross-complementation group 4 | 7 | 6 | |
ERCC5 | 109 | excision repair cross-complementation group 5 | 5 | 10 | |
ERCC6 | 92 | excision repair cross-complementation group 6 | 16 | 32 | |
ERCC8 | 12 | excision repair cross-complementation group 8 | 10 | 16 | |
ESR1 | 216 | estrogen receptor 1 | 23 | 127 | |
FAS | 115 | Fas cell surface death receptor | 26 | 25 | |
FEN1 | 114 | flap structure-specific endonuclease 1 | 10 | 22 | |
FGF21 | 293 | fibroblast growth factor 21 | 0 | 0 | |
FGF23 | 259 | fibroblast growth factor 23 | 8 | 2 | |
FGFR1 | 169 | fibroblast growth factor receptor 1 | 8 | 15 | |
FLT1 | 171 | fms-related tyrosine kinase 1 | 3 | 8 | |
FOS | 50 | FBJ murine osteosarcoma viral oncogene homolog | 19 | 47 | |
FOXM1 | 131 | forkhead box M1 | 21 | 24 | |
FOXO1 | 124 | forkhead box O1 | 43 | 33 | |
FOXO3 | 123 | forkhead box O3 | 56 | 34 | |
FOXO4 | 183 | forkhead box O4 | 19 | 18 | |
GCLC | 237 | glutamate-cysteine ligase, catalytic subunit | 7 | 2 | |
GCLM | 238 | glutamate-cysteine ligase, modifier subunit | 6 | 4 | |
GDF11 | 309 | growth differentiation factor 11 | 0 | 0 | |
GH1 | 26 | growth hormone 1 | 66 | 4 | |
GHR | 1 | growth hormone receptor | 32 | 23 | |
GHRH | 2 | growth hormone releasing hormone | 14 | 2 | |
GHRHR | 222 | growth hormone releasing hormone receptor | 16 | 2 | |
GPX1 | 153 | glutathione peroxidase 1 | 27 | 4 | |
GPX4 | 257 | glutathione peroxidase 4 | 2 | 6 | |
GRB2 | 122 | growth factor receptor-bound protein 2 | 7 | 77 | |
GRN | 300 | granulin | 0 | 8 | |
GSK3A | 295 | glycogen synthase kinase 3 alpha | 0 | 26 | |
GSK3B | 97 | glycogen synthase kinase 3 beta | 7 | 67 | |
GSR | 154 | glutathione reductase | 12 | 7 | |
GSS | 155 | glutathione synthetase | 6 | 3 | |
GSTA4 | 156 | glutathione S-transferase alpha 4 | 8 | 1 | |
GSTP1 | 157 | glutathione S-transferase pi 1 | 13 | 9 | |
GTF2H2 | 111 | general transcription factor IIH, polypeptide 2, 44kDa | 3 | 10 | |
H2AFX | 212 | H2A histone family, member X | 12 | 76 | |
HBP1 | 196 | HMG-box transcription factor 1 | 5 | 14 | |
HDAC1 | 151 | histone deacetylase 1 | 11 | 117 | |
HDAC2 | 207 | histone deacetylase 2 | 7 | 77 | |
HDAC3 | 25 | histone deacetylase 3 | 7 | 59 | |
HELLS | 101 | helicase, lymphoid-specific | 6 | 12 | |
HESX1 | 184 | HESX homeobox 1 | 4 | 4 | |
HIC1 | 253 | hypermethylated in cancer 1 | 2 | 9 | |
HIF1A | 65 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 17 | 62 | |
HMGB1 | 176 | high mobility group box 1 | 9 | 30 | |
HMGB2 | 178 | high mobility group box 2 | 5 | 10 | |
HOXB7 | 213 | homeobox B7 | 5 | 14 | |
HOXC4 | 214 | homeobox C4 | 4 | 8 | |
HRAS | 38 | Harvey rat sarcoma viral oncogene homolog | 21 | 12 | |
HSF1 | 125 | heat shock transcription factor 1 | 23 | 31 | |
HSP90AA1 | 74 | heat shock protein 90kDa alpha (cytosolic), class A member 1 | 10 | 133 | |
HSPA1A | 160 | heat shock 70kDa protein 1A | 31 | 56 | |
HSPA1B | 161 | heat shock 70kDa protein 1B | 4 | 16 | |
HSPA8 | 199 | heat shock 70kDa protein 8 | 12 | 84 | |
HSPA9 | 152 | heat shock 70kDa protein 9 (mortalin) | 4 | 40 | |
HSPD1 | 159 | heat shock 60kDa protein 1 (chaperonin) | 6 | 52 | |
HTRA2 | 294 | HtrA serine peptidase 2 | 0 | 11 | |
HTT | 98 | huntingtin | 17 | 35 | |
IFNB1 | 308 | Interferon beta | 0 | 1 | |
IGF1 | 28 | insulin-like growth factor 1 (somatomedin C) | 118 | 8 | |
IGF1R | 15 | insulin-like growth factor 1 receptor | 36 | 34 | |
IGF2 | 29 | insulin-like growth factor 2 | 21 | 2 | |
IGFBP2 | 279 | insulin-like growth factor binding protein 2, 36kDa | 1 | 2 | |
IGFBP3 | 73 | insulin-like growth factor binding protein 3 | 10 | 8 | |
IKBKB | 297 | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0 | 53 | |
IL2 | 46 | interleukin 2 | 7 | 2 | |
IL2RG | 49 | interleukin 2 receptor, gamma | 2 | 6 | |
IL6 | 144 | interleukin 6 | 23 | 0 | |
IL7 | 167 | interleukin 7 | 6 | 2 | |
IL7R | 27 | interleukin 7 receptor | 5 | 4 | |
INS | 30 | insulin | 77 | 4 | |
INSR | 42 | insulin receptor | 33 | 26 | |
IRS1 | 32 | insulin receptor substrate 1 | 21 | 48 | |
IRS2 | 34 | insulin receptor substrate 2 | 16 | 26 | |
JAK2 | 215 | Janus kinase 2 | 9 | 49 | |
JUN | 172 | jun proto-oncogene | 22 | 101 | |
JUND | 45 | jun D proto-oncogene | 7 | 24 | |
KCNA3 | 268 | potassium channel, voltage gated shaker related subfamily A, member 3 | 6 | 2 | |
KL | 17 | klotho | 33 | 0 | |
LEP | 217 | leptin | 36 | 2 | |
LEPR | 218 | leptin receptor | 14 | 2 | |
LMNA | 14 | lamin A/C | 61 | 43 | |
LMNB1 | 181 | lamin B1 | 5 | 18 | |
LRP2 | 134 | low density lipoprotein receptor-related protein 2 | 2 | 8 | |
MAP3K5 | 179 | mitogen-activated protein kinase kinase kinase 5 | 4 | 29 | |
MAPK14 | 168 | mitogen-activated protein kinase 14 | 28 | 55 | |
MAPK3 | 175 | mitogen-activated protein kinase 3 | 12 | 39 | |
MAPK8 | 163 | mitogen-activated protein kinase 8 | 26 | 71 | |
MAPK9 | 174 | mitogen-activated protein kinase 9 | 16 | 33 | |
MAPT | 205 | microtubule-associated protein tau | 35 | 39 | |
MAX | 208 | MYC associated factor X | 5 | 31 | |
MDM2 | 210 | MDM2 proto-oncogene, E3 ubiquitin protein ligase | 9 | 115 | |
MED1 | 173 | mediator complex subunit 1 | 2 | 25 | |
MIF | 290 | macrophage migration inhibitory factor (glycosylation-inhibiting factor) | 0 | 9 | |
MLH1 | 243 | mutL homolog 1 | 5 | 28 | |
MSRA | 127 | methionine sulfoxide reductase A | 11 | 0 | |
MT-CO1 | 158 | mitochondrially encoded cytochrome c oxidase I | 5 | 1 | |
MT1E | 292 | metallothionein 1E | 0 | 0 | |
MTOR | 221 | mechanistic target of rapamycin (serine/threonine kinase) | 26 | 49 | |
MXD1 | 209 | MAX dimerization protein 1 | 2 | 14 | |
MXI1 | 90 | MAX interactor 1, dimerization protein | 3 | 6 | |
MYC | 39 | v-myc avian myelocytomatosis viral oncogene homolog | 22 | 119 | |
NBN | 44 | nibrin | 22 | 38 | |
NCOR1 | 43 | nuclear receptor corepressor 1 | 6 | 60 | |
NCOR2 | 276 | nuclear receptor corepressor 2 | 1 | 52 | |
NFE2L1 | 307 | nuclear factor, erythroid 2-like 1 | 0 | 5 | |
NFE2L2 | 283 | nuclear factor, erythroid 2-like 2 | 7 | 36 | |
NFKB1 | 82 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 25 | 59 | |
NFKB2 | 20 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 24 | 17 | |
NFKBIA | 219 | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 9 | 42 | |
NGF | 31 | nerve growth factor (beta polypeptide) | 13 | 4 | |
NGFR | 37 | nerve growth factor receptor | 5 | 13 | |
NOG | 229 | noggin | 7 | 1 | |
NR3C1 | 75 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 14 | 69 | |
NRG1 | 24 | neuregulin 1 | 6 | 6 | |
NUDT1 | 296 | nudix (nucleoside diphosphate linked moiety X)-type motif 1 | 0 | 0 | |
PAPPA | 254 | pregnancy-associated plasma protein A, pappalysin 1 | 8 | 2 | |
PARP1 | 60 | poly (ADP-ribose) polymerase 1 | 39 | 91 | |
PCK1 | 248 | phosphoenolpyruvate carboxykinase 1 (soluble) | 2 | 8 | |
PCMT1 | 162 | protein-L-isoaspartate (D-aspartate) O-methyltransferase | 5 | 20 | |
PCNA | 113 | proliferating cell nuclear antigen | 12 | 67 | |
PDGFB | 47 | platelet-derived growth factor beta polypeptide | 7 | 5 | |
PDGFRA | 285 | platelet-derived growth factor receptor, alpha polypeptide | 4 | 17 | |
PDGFRB | 51 | platelet-derived growth factor receptor, beta polypeptide | 4 | 23 | |
PDPK1 | 87 | 3-phosphoinositide dependent protein kinase 1 | 4 | 11 | |
PEX5 | 58 | peroxisomal biogenesis factor 5 | 4 | 10 | |
PIK3CA | 286 | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha | 1 | 20 | |
PIK3CB | 36 | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta | 22 | 12 | |
PIK3R1 | 185 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 16 | 65 | |
PIN1 | 62 | peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 9 | 46 | |
PLAU | 10 | plasminogen activator, urokinase | 9 | 8 | |
PLCG2 | 57 | phospholipase C, gamma 2 (phosphatidylinositol-specific) | 6 | 18 | |
PMCH | 242 | pro-melanin-concentrating hormone | 6 | 0 | |
PML | 96 | promyelocytic leukemia | 11 | 89 | |
POLA1 | 204 | polymerase (DNA directed), alpha 1, catalytic subunit | 9 | 22 | |
POLB | 236 | polymerase (DNA directed), beta | 14 | 16 | |
POLD1 | 118 | polymerase (DNA directed), delta 1, catalytic subunit | 11 | 14 | |
POLG | 72 | polymerase (DNA directed), gamma | 11 | 0 | |
PON1 | 142 | paraoxonase 1 | 10 | 2 | |
POU1F1 | 4 | POU class 1 homeobox 1 | 20 | 14 | |
PPARA | 55 | peroxisome proliferator-activated receptor alpha | 13 | 22 | |
PPARG | 263 | peroxisome proliferator-activated receptor gamma | 8 | 63 | |
PPARGC1A | 256 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 15 | 30 | |
PPM1D | 246 | protein phosphatase, Mg2+/Mn2+ dependent, 1D | 1 | 4 | |
PPP1CA | 227 | protein phosphatase 1, catalytic subunit, alpha isozyme | 3 | 56 | |
PRDX1 | 141 | peroxiredoxin 1 | 4 | 29 | |
PRKCA | 99 | protein kinase C, alpha | 4 | 39 | |
PRKCD | 54 | protein kinase C, delta | 4 | 41 | |
PRKDC | 106 | protein kinase, DNA-activated, catalytic polypeptide | 16 | 89 | |
PROP1 | 5 | PROP paired-like homeobox 1 | 29 | 2 | |
PSEN1 | 224 | presenilin 1 | 18 | 15 | |
PTEN | 63 | phosphatase and tensin homolog | 16 | 46 | |
PTGS2 | 198 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 11 | 15 | |
PTK2 | 166 | protein tyrosine kinase 2 | 5 | 43 | |
PTK2B | 165 | protein tyrosine kinase 2 beta | 2 | 23 | |
PTPN1 | 33 | protein tyrosine phosphatase, non-receptor type 1 | 5 | 28 | |
PTPN11 | 19 | protein tyrosine phosphatase, non-receptor type 11 | 7 | 47 | |
PYCR1 | 280 | pyrroline-5-carboxylate reductase 1 | 1 | 2 | |
RAD51 | 84 | RAD51 recombinase | 10 | 37 | |
RAD52 | 147 | RAD52 homolog, DNA repair protein | 3 | 27 | |
RAE1 | 241 | ribonucleic acid export 1 | 2 | 12 | |
RB1 | 120 | retinoblastoma 1 | 46 | 96 | |
RECQL4 | 128 | RecQ helicase-like 4 | 11 | 8 | |
RELA | 143 | v-rel avian reticuloendotheliosis viral oncogene homolog A | 32 | 93 | |
RET | 56 | ret proto-oncogene | 4 | 15 | |
RGN | 145 | regucalcin | 6 | 2 | |
RICTOR | 303 | RPTOR independent companion of MTOR, complex 2 | 0 | 20 | |
RPA1 | 67 | replication protein A1, 70kDa | 5 | 73 | |
S100B | 70 | S100 calcium binding protein B | 7 | 7 | |
SDHC | 182 | succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa | 5 | 4 | |
SERPINE1 | 301 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0 | 3 | |
SHC1 | 3 | SHC (Src homology 2 domain containing) transforming protein 1 | 29 | 67 | |
SIN3A | 200 | SIN3 transcription regulator family member A | 3 | 34 | |
SIRT1 | 150 | sirtuin 1 | 82 | 95 | |
SIRT3 | 275 | sirtuin 3 | 4 | 12 | |
SIRT6 | 239 | sirtuin 6 | 15 | 28 | |
SIRT7 | 269 | sirtuin 7 | 3 | 38 | |
SLC13A1 | 270 | solute carrier family 13 (sodium/sulfate symporter), member 1 | 3 | 0 | |
SNCG | 140 | synuclein, gamma (breast cancer-specific protein 1) | 5 | 8 | |
SOCS2 | 271 | suppressor of cytokine signaling 2 | 7 | 12 | |
SOD1 | 130 | superoxide dismutase 1, soluble | 45 | 29 | |
SOD2 | 129 | superoxide dismutase 2, mitochondrial | 55 | 11 | |
SP1 | 170 | Sp1 transcription factor | 13 | 93 | |
SPRTN | 302 | SprT-like N-terminal domain | 0 | 20 | |
SQSTM1 | 298 | sequestosome 1 | 0 | 49 | |
SST | 53 | somatostatin | 8 | 2 | |
SSTR3 | 100 | somatostatin receptor 3 | 2 | 2 | |
STAT3 | 22 | signal transducer and activator of transcription 3 (acute-phase response factor) | 13 | 83 | |
STAT5A | 23 | signal transducer and activator of transcription 5A | 5 | 35 | |
STAT5B | 21 | signal transducer and activator of transcription 5B | 5 | 21 | |
STK11 | 93 | serine/threonine kinase 11 | 5 | 18 | |
STUB1 | 245 | STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase | 1 | 69 | |
SUMO1 | 211 | small ubiquitin-like modifier 1 | 6 | 49 | |
SUN1 | 277 | Sad1 and UNC84 domain containing 1 | 1 | 0 | |
TAF1 | 180 | TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa | 1 | 26 | |
TBP | 194 | TATA box binding protein | 6 | 45 | |
TCF3 | 59 | transcription factor 3 | 7 | 13 | |
TERC | 7 | telomerase RNA component | 34 | 2 | |
TERF1 | 105 | telomeric repeat binding factor (NIMA-interacting) 1 | 9 | 45 | |
TERF2 | 116 | telomeric repeat binding factor 2 | 18 | 43 | |
TERT | 8 | telomerase reverse transcriptase | 62 | 32 | |
TFAP2A | 190 | transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | 7 | 30 | |
TFDP1 | 202 | transcription factor Dp-1 | 4 | 14 | |
TGFB1 | 91 | transforming growth factor, beta 1 | 25 | 2 | |
TNF | 86 | tumor necrosis factor | 20 | 11 | |
TOP1 | 83 | topoisomerase (DNA) I | 9 | 36 | |
TOP2A | 80 | topoisomerase (DNA) II alpha | 8 | 42 | |
TOP2B | 81 | topoisomerase (DNA) II beta | 8 | 24 | |
TOP3B | 148 | topoisomerase (DNA) III beta | 7 | 4 | |
TP53 | 6 | tumor protein p53 | 139 | 221 | |
TP53BP1 | 274 | tumor protein p53 binding protein 1 | 7 | 42 | |
TP63 | 234 | tumor protein p63 | 9 | 37 | |
TP73 | 281 | tumor protein p73 | 3 | 41 | |
TPP2 | 273 | tripeptidyl peptidase II | 2 | 4 | |
TRAP1 | 305 | TNF receptor-associated protein 1 | 0 | 12 | |
TRPV1 | 306 | transient receptor potential cation channel subfamily V member 1 | 0 | 3 | |
TXN | 16 | thioredoxin | 15 | 30 | |
UBB | 66 | ubiquitin B | 8 | 10 | |
UBE2I | 85 | ubiquitin-conjugating enzyme E2I | 5 | 113 | |
UCHL1 | 136 | ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) | 6 | 22 | |
UCP1 | 258 | uncoupling protein 1 (mitochondrial, proton carrier) | 5 | 0 | |
UCP2 | 235 | uncoupling protein 2 (mitochondrial, proton carrier) | 22 | 2 | |
UCP3 | 232 | uncoupling protein 3 (mitochondrial, proton carrier) | 22 | 2 | |
VCP | 71 | valosin containing protein | 3 | 83 | |
VEGFA | 77 | vascular endothelial growth factor A | 15 | 7 | |
WRN | 13 | Werner syndrome, RecQ helicase-like | 88 | 47 | |
XPA | 126 | xeroderma pigmentosum, complementation group A | 15 | 18 | |
XRCC5 | 112 | X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining) | 24 | 69 | |
XRCC6 | 117 | X-ray repair complementing defective repair in Chinese hamster cells 6 | 19 | 79 | |
YWHAZ | 164 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta | 3 | 59 | |
ZMPSTE24 | 233 | zinc metallopeptidase STE24 | 13 | 2 |
Entry selected based on evidence directly linking the gene product to ageing in humans |
Entry selected based on evidence directly linking the gene product to ageing in a mammalian model organism |
Entry selected based on evidence directly linking the gene product to ageing in a non-mammalian animal model |
Entry selected based on evidence directly linking the gene product to ageing in a cellular model system |
Entry selected based on evidence linking the gene or its product to human longevity and/or multiple age-related phenotypes |
Entry selected based on evidence linking the gene product to the regulation or control of genes previously linked to ageing |
Entry selected based on evidence linking the gene product to a pathway or mechanism linked to ageing |
Entry selected based on indirect or inconclusive evidence linking the gene product to ageing or showing the gene product to be an effector of genes related to ageing |
Source: HAGR